Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome.

Ferretti G, Bacchetti T, Masciangelo S, Grugni G, Bicchiega V.

Dis Model Mech. 2012 Sep;5(5):698-705. doi: 10.1242/dmm.009209. Epub 2012 Jul 19.

2.

Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects.

Caixàs A, Giménez-Palop O, Broch M, Vilardell C, Megía A, Simón I, Giménez-Pérez G, Mauricio D, Vendrell J, Richart C, González-Clemente JM.

J Endocrinol Invest. 2008 Feb;31(2):169-75.

PMID:
18362510
3.

HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.

Ferretti G, Bacchetti T, Masciangelo S, Bicchiega V.

Obesity (Silver Spring). 2010 Jun;18(6):1079-84. doi: 10.1038/oby.2009.338. Epub 2009 Oct 15.

4.

Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.

Ferretti G, Bacchetti T, Moroni C, Savino S, Liuzzi A, Balzola F, Bicchiega V.

J Clin Endocrinol Metab. 2005 Mar;90(3):1728-33. Epub 2004 Dec 21.

PMID:
15613429
5.

Metabolic syndrome in adult patients with Prader-Willi syndrome.

Grugni G, Crinò A, Bedogni G, Cappa M, Sartorio A, Corrias A, Di Candia S, Gargantini L, Iughetti L, Pagano C, Ragusa L, Salvatoni A, Spera S, Vettor R, Chiumello G, Brambilla P.

Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1134-40. doi: 10.1016/j.numecd.2012.11.006. Epub 2012 Dec 7.

PMID:
23220075
6.

Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance.

Viardot A, Sze L, Purtell L, Sainsbury A, Loughnan G, Smith E, Herzog H, Steinbeck K, Campbell LV.

J Clin Endocrinol Metab. 2010 Jul;95(7):3392-9. doi: 10.1210/jc.2009-2492. Epub 2010 May 5.

PMID:
20444923
7.

Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects.

Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG.

Int J Obes (Lond). 2006 Feb;30(2):382-7.

PMID:
16231029
8.

Comparison of leptin protein levels in Prader-Willi syndrome and control individuals.

Butler MG, Moore J, Morawiecki A, Nicolson M.

Am J Med Genet. 1998 Jan 6;75(1):7-12.

PMID:
9450849
9.

Serum paraoxonase enzyme activity and oxidative stress in obese subjects.

Aslan M, Horoz M, Sabuncu T, Celik H, Selek S.

Pol Arch Med Wewn. 2011 Jun;121(6):181-6.

11.
12.

Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.

Rigamonti AE, Grugni G, Marazzi N, Bini S, Bidlingmaier M, Sartorio A.

Growth Horm IGF Res. 2015 Aug;25(4):168-73. doi: 10.1016/j.ghir.2015.06.002. Epub 2015 Jun 3.

PMID:
26059749
13.

In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.

Purtell L, Sze L, Loughnan G, Smith E, Herzog H, Sainsbury A, Steinbeck K, Campbell LV, Viardot A.

Neuropeptides. 2011 Aug;45(4):301-7. doi: 10.1016/j.npep.2011.06.001. Epub 2011 Jul 1.

PMID:
21722955
14.

Analysis of endothelial protein C receptor gene and metabolic profile in Prader-Willi syndrome and obese subjects.

Faienza MF, Ventura A, Lauciello R, Crinò A, Ragusa L, Cavallo L, Spera S, Grugni G.

Obesity (Silver Spring). 2012 Sep;20(9):1866-70. doi: 10.1038/oby.2011.349. Epub 2011 Dec 22.

15.

Peculiar body composition in patients with Prader-Labhart-Willi syndrome.

Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, Chiumello G.

Am J Clin Nutr. 1997 May;65(5):1369-74.

PMID:
9129464
16.

Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.

Schuster DP, Osei K, Zipf WB.

Metabolism. 1996 Dec;45(12):1514-20.

PMID:
8969285
17.
18.

Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects.

Butler MG, Carlson MG, Schmidt DE, Feurer ID, Thompson T.

Am J Med Genet. 2000 Nov 6;95(1):67-70.

PMID:
11074497
19.

Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.

Bacchetti T, Campanati A, Ferretti G, Simonetti O, Liberati G, Offidani AM.

Br J Dermatol. 2013 May;168(5):984-9. doi: 10.1111/bjd.12144.

PMID:
23614561
20.

Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.

Bizzarri C, Rigamonti AE, Luce A, Cappa M, Cella SG, Berini J, Sartorio A, Müller EE, Salvatoni A.

Eur J Endocrinol. 2010 Mar;162(3):499-505. doi: 10.1530/EJE-09-1033. Epub 2009 Dec 17.

Supplemental Content

Support Center